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Introduction. At a global level, viral hepatitis is responsible for 144 million deaths every year. 
Chronic viral hepatitis presents today one of the most serious health and socioeconomic problems in 
Moldova. Annually there are more than 10,000 illnesses, the incidence reaching - 150 cases per 100 
thousand population.
Purpose. Analysis of cytolysis syndrome evolution in patients with chronic viral hepatitis B, C, 
D ambulatory and in the hospital.
Materials ant methods. The study included 126 patients, of which 102 were hospitalized during 
the years 2010-2015 in gastroenterology ward, Clinical Hospital Central Railway st. Chisinau and 24 
patients ambulatory treated in the period September to December 2015 in CS Falesti. I have done a 
survey retrospectively and prospectively. Outpatients were treated only with hepatoprotective -
silymarin administered for a month, and those in hospital administered for 10 days: silymarin, 
pentoxifylline (antifibrotic), ursodeoxycholic acid and Vit. C, B1, B6, B12.
Results. Using the distribution of HBV patients according to cytolytic indexes after treatment, 
inpatient was revealed that 11 patients (47.72%) out of those hospitalized with moderate hepatitis 
activity and 14 patients (50%) out of those with minimal activity, recorded values in the normal limits 
of enzymes ALT and AST at the discharge. Ambulatory, only one patient (9.09%) out of 16 patients 
obtained transaminases values within the norm. All 10 patients (100%) of those hospitalized with HCV 
minimal activity, showed values within normal levels of liver enzymes. Outpatient, no patient with HCV 
obtained positive dynamics of cytolytic syndrome. Patients with HBV + HCV discharged from hospital 
were all having minimum activity of liver enzymes. Outpatient there were not registered positive 
dynamics. Analyzing the distribution of patients with HBV + HDV in hospital, 3 patients (42.86%) out 
of the 7 patients that were hospitalized with moderate activity hepatitis, achieved minimum activity of 
enzymes ALT and AST. Outpatient – without any positive dynamics. 
Conclusions. During the survey, I paid attention that the most obvious improvement of 
transaminases happened with the patients that were receiving inpatient treatment compared to outpatient 
treatment, although hepatoprotective treatment duration is longer in the ambulatory. But perhaps that 
including vitamins, ursodeoxycholic acid and antifibrotic medicaments into patients’ treatment favored 
efficacy in reducing faster transaminases, which shows the necessity of treatment in hospital for patients 
with chronic viral hepatitis, which would bring only benefits for both patient’s health and state economy 
by reducing human morbidity,as well with shortening disease treatment and time that patients spend on 
treatment process. 
Key words. chronic viral hepatitis, cytolysis syndrome, treatment.
105
